Development
E
Cardlytics, Inc. CDLX
$1.79 $0.116.55% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income 73.34% -482.42% 81.39% -58.81% -3,096.27%
Total Depreciation and Amortization -21.24% -43.94% -30.64% -31.41% -24.08%
Total Amortization of Deferred Charges 2.73% 3.23% 6.19% 1.24% -90.28%
Total Other Non-Cash Items -72.31% 159.63% -77.53% 43.96% 34,901.90%
Change in Net Operating Assets 51.13% -205.36% -110.02% 72.47% -196.70%
Cash from Operations 122.40% 108.27% 186.12% 48.89% -2,260.54%
Capital Expenditure -238.27% 74.63% 103.66% 9.32% 91.59%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -11.43% 0.26% 26.79% -3.34% -25.34%
Cash from Investing 56.64% 4.78% 35.65% 44.34% 7.64%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 9.09% -233.33% 12.50% 69.23% --
Issuance of Common Stock -- 1,000.00% -94.44% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 138.67% -85.71% -28,681.61% -- --
Cash from Financing 126.82% 450.00% -25.24% 16,373.08% -179.56%
Foreign Exchange rate Adjustments 144.12% 90.60% 82.39% 127.76% 2.30%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 110.18% 89.18% 8.07% 168.68% -323.76%